JPMorgan lowered the firm’s price target on Teradyne (TER) to $145 from $158 and keeps an Overweight rating on the shares post the Q4 report.
KeyBanc lowered the firm’s price target on Teradyne (TER) to $150 from $180 and keeps an Overweight rating on the shares. The firm notes shares ...